BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36798741)

  • 1. Behaviour within a Clinical Trial and Implications for Mammography Guidelines.
    Kowalski AE
    Rev Econ Stud; 2023 Jan; 90(1):432-462. PubMed ID: 36798741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort.
    Ryser MD; Lange J; Inoue LYT; O'Meara ES; Gard C; Miglioretti DL; Bulliard JL; Brouwer AF; Hwang ES; Etzioni RB
    Ann Intern Med; 2022 Apr; 175(4):471-478. PubMed ID: 35226520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
    Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
    Autier P; Boniol M; Koechlin A; Pizot C; Boniol M
    BMJ; 2017 Dec; 359():j5224. PubMed ID: 29208760
    [No Abstract]   [Full Text] [Related]  

  • 9. Another round in the mammography controversy.
    Meissner HI; Rimer BK; Davis WW; Eisner EJ; Siegler IC
    J Womens Health (Larchmt); 2003 Apr; 12(3):261-76. PubMed ID: 12804357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of first mammography examination in women younger than 40 years.
    Yankaskas BC; Haneuse S; Kapp JM; Kerlikowske K; Geller B; Buist DS;
    J Natl Cancer Inst; 2010 May; 102(10):692-701. PubMed ID: 20439838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will supplemental screening ultrasound increase breast cancer overdiagnosis?
    Molleran VM
    Acad Radiol; 2015 Aug; 22(8):967-72. PubMed ID: 26100187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study.
    Ro V; Jones T; Silverman T; McGuinness JE; Guzman A; Amenta J; Kukafka R; Crew KD
    BMC Cancer; 2022 Jul; 22(1):819. PubMed ID: 35897000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital mammography screening: weighing reduced mortality against increased overdiagnosis.
    de Gelder R; Fracheboud J; Heijnsdijk EA; den Heeten G; Verbeek AL; Broeders MJ; Draisma G; de Koning HJ
    Prev Med; 2011 Sep; 53(3):134-40. PubMed ID: 21718717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
    Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K
    Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.
    Zahl PH; Jørgensen KJ; Gøtzsche PC
    Br J Cancer; 2013 Oct; 109(7):2014-9. PubMed ID: 23963144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving screening recall services for women with false-positive mammograms: a comparison of qualitative evidence with UK guidelines.
    Bond M; Garside R; Hyde C
    BMJ Open; 2015 Jan; 5(1):e005855. PubMed ID: 25618139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammograms and Mortality: How Has the Evidence Evolved?
    Kowalski AE
    J Econ Perspect; 2021; 35(2):119-140. PubMed ID: 34421215
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.